Filovirus entry

Advances in Experimental Medicine and Biology

Volumn 790, Issue , 2013, Pages 83-94

  Simmons, Graham ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATTACHMENT FACTOR; CD209 ANTIGEN; GLYCOSAMINOGLYCAN; PROTEINASE; UNCLASSIFIED DRUG; VIRUS FUSION PROTEIN; VIRUS GLYCOPROTEIN; VIRUS PROTEIN; VIRUS RECEPTOR;

ARTICLE; ENDOCYTOSIS; FILOVIRUS; HOST CELL; LIVER CELL; MACROPHAGE; MEMBRANE FUSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; VIRAL TROPISM; VIRUS ATTACHMENT; VIRUS ENTRY; VIRUS REPLICATION;

ANIMALS; FILOVIRIDAE; HUMANS; MEMBRANE FUSION; RECEPTORS, VIRUS; VIRUS INTERNALIZATION;

EID: 84881441178     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-7651-1_5     Document Type: Article

References (93)

1. Leroy EM, Gonzalez J-P, Baize S. Ebola and Marburg haemorrhagic fever viruses: major scientific advances, but a relatively minor public health threat for Africa. Clin Microbiol Infect 2011; 17:964-976.
2. Leroy EM, Kumulungui B, Pourrut X et al. Fruit bats as reservoirs of Ebola virus. Nature 2005; 438:575-576.
3. Towner JS, Amman BR, Sealy TK et al. Isolation of genetically diverse Marburg viruses from Egyptian fruit bats. PLoS Pathog 2009; 5:e1000536.
4. Barrette RW, Metwally SA, Rowland JM et al. Discovery of swine as a host for the reston Ebola virus. Science 2009; 325:204-206.
5. Volchkov VE, Becker S, Volchkova VA et al. GP mRNA of Ebola virus is edited by the Ebola virus polymerase and by T7 and vaccinia virus polymerases. Virology 1995; 214:421-430.
6. Sanchez A, Ksiazek TG, Rollin PE et al. Detection and molecular characterization of Ebola viruses causing disease in human and nonhuman primates. J Infect Dis 1999; 179(Suppl 1):S164-169.
7. Volchkov VE, Volchkova VA, Muhlberger E et al. Recovery of infectious Ebola virus from complementary DNA: RNA editing of the GP gene and viral cytotoxicity. Science 2001; 291:1965-1969.
8. Yang ZY, Duckers HJ, Sullivan NJ et al. Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury. Nat Med 2000; 6:886-889.
9. Simmons G, Wool-Lewis RJ, Baribaud F et al. Ebola virus glycoproteins induce global surface protein down-modulation and loss of cell adherence. J Viro 2002; 76:2518-2528.
10. Marzi A, Wegele A, Pohlmann S. Modulation of virion incorporation of Ebolavirus glycoprotein: Effects on attachment, cellular entry and neutralization. Virology 2006; 352:345-56.
11. Volchkov VE, Feldmann H, Volchkova VA et al. Processing of the Ebola virus glycoprotein by the proprotein convertase furin. Proc Natl Acad Sci USA 1998; 95:5762-5767.
12. Volchkov VE, Volchkova VA, Stroher U et al. Proteolytic processing of Marburg virus glycoprotein. Virology 2000; 268:1-6.
13. Jeffers SA, Sanders DA, Sanchez A. Covalent modifications of the ebola virus glycoprotein. J Virol 2002; 76:12463-12472.
14. Klenk HD, Garten W. Host cell proteases controlling virus pathogenicity. Trends Microbiol 1994; 2:39-43.
15. Wool-Lewis RJ, Bates P. Endoproteolytic processing of the ebola virus envelope glycoprotein: cleavage is not required for function. J Virol 1999; 73:1419-1426.
16. Neumann G, Geisbert TW, Ebihara H et al. Proteolytic processing of the Ebola virus glycoprotein is not critical for Ebola virus replication in nonhuman primates. J Virol 2007; 81:2995-2998.
17. Weissenhorn W, Carfi A, Lee KH et al. Crystal structure of the Ebola virus membrane fusion subunit, GP2, from the envelope glycoprotein ectodomain. Mol Cell 1998; 2:605-616.
18. White JM, Delos SE, Brecher M, Schornberg K. Structures and mechanisms of viral membrane fusion proteins. Crit Rev Biochem Mol Biol 2008; 43(3):189-219.
19. Geyer H, Will C, Feldmann H et al. Carbohydrate structure of Marburg virus glycoprotein. Glycobiology 1992; 2:299-312.
20. Lee JE, Fusco ML, Hessell AJ et al. Structure of the ebola virus glycoprotein bound to an antibody from a human survivor. Nature 2008; 454:177-182.
21. Sinn PL, Hickey MA, Staber PD et al. Lentivirus vectors pseudotyped with filoviral envelope glycoproteins transduce airway epithelia from the apical surface independently of folate receptor alpha. J Virol 2003; 77:5902-5910.
22. Manicassamy B, Wang J, Jiang H et al. Comprehensive analysis of ebola virus GP1 in viral entry. J Virol 2005; 79:4793-4805.
23. Kuhn JH, Radoshitzky SR, Guth AC et al. Conserved receptor-binding domains of Lake Victoria marburgvirus and Zaire ebolavirus bind a common receptor. J Biol Chem 2006; 281:15951-15958.
24. Mpanju OM, Towner JS, Dover JE et al. Identification of two amino acid residues on Ebola virus glycoprotein 1 critical for cell entry. Virus Res 2006; 121:205-14.
25. Takada A, Robison C, Goto H et al. A system for functional analysis of Ebola virus glycoprotein. Proc Natl Acad Sci USA 1997; 94:14764-14769.
26. Wool-Lewis RJ, Bates P. Characterization of Ebola virus entry by using pseudotyped viruses: identification of receptor-deficient cell lines. J Virol 1998; 72:3155-3160.
27. Chan SY, Speck RF, Ma MC et al. Distinct mechanisms of entry by envelope glycoproteins of Marburg and Ebola (Zaire) viruses. J Virol 2000; 74:4933-4937.
28. Ito H, Watanabe S, Takada A et al. Ebola Virus Glycoprotein: Proteolytic Processing, Acylation, Cell Tropism, and Detection of Neutralizing Antibodies. J Virol 2001; 75:1576-1580.
29. Geisbert TW, Hensley LE, Gibb TR et al. Apoptosis induced in vitro and in vivo during infection by Ebola and Marburg viruses. Lab Invest 2000; 80:171-186.
30. Schnittler HJ, Feldmann H. Molecular pathogenesis of filovirus infections: role of macrophages and endothelial cells. Curr Top Microbiol Immunol 1999; 235:175-204.
31. Schnittler HJ, Feldmann H. Marburg and Ebola hemorrhagic fevers: does the primary course of infection depend on the accessibility of organ-specific macrophages? Clin Infect Dis 1998; 27:404-406.
32. Stroher U, West E, Bugany H et al. Infection and activation of monocytes by Marburg and Ebola viruses. J Virol 2001; 75:11025-11033.
33. Yonezawa A, Cavrois M, Greene WC. Studies of ebola virus glycoprotein-mediated entry and fusion by using pseudotyped human immunodeficiency virus type 1 virions: involvement of cytoskeletal proteins and enhancement by tumor necrosis factor alpha. J Virol 2005; 79:918-926.
34. Bosio CM, Aman MJ, Grogan C et al. Ebola and Marburg viruses replicate in monocyte-derived dendritic cells without inducing the production of cytokines and full maturation. J Infect Dis 2003; 188:1630-1638.
35. Kondratowicz AS, Lennemann NJ, Sinn PL et al. T-cell immunoglobulin and mucin domain 1 (tim- 1) is a receptor for zaire ebolavirus and lake victoria marburgvirus. Proc Natl Acad Sci USA 2011; 108:8426-8431.
36. Shimojima M, Takada A, Ebihara H et al. Tyro3 family-mediated cell entry of Ebola and Marburg viruses. J Virol 2006; 80:10109-10116.
37. Brindley MA, Hunt CL, Kondratowicz AS et al. Tyrosine kinase receptor axl enhances entry of zaire ebolavirus without direct interactions with the viral glycoprotein. Virology 2011; 415:83-94.
38. Chan SY, Empig CJ, Welte FJ et al. Folate receptor-alpha is a cofactor for cellular entry by Marburg and Ebola viruses. Cell 2001; 106:117-126.
39. Simmons G, Rennekamp AJ, Chai N et al. Folate receptor alpha and caveolae are not required for Ebola virus glycoprotein-mediated viral infection. J Virol 2003; 77:13433-13438.
40. Takada A, Watanabe S, Ito H et al. Downregulation of beta1 integrins by Ebola virus glycoprotein: implication for virus entry. Virology 2000; 278:20-26.
41. O'Doherty U, Swiggard WJ, Malim MH. Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding. J Virol 2000; 74:10074-10080.
42. Soilleux EJ, Barten R, Trowsdale J. DC-SIGN; a related gene, DC-SIGNR; and CD23 form a cluster on 19p13. J Immunol 2000; 165:2937-2942.
43. Liu W, Tang L, Zhang G et al. Characterization of a novel C-type lectin-like gene, LSECtin: demonstration of carbohydrate binding and expression in sinusoidal endothelial cells of liver and lymph node. J Biol Chem 2004; 279:18748-18758.
44. Geijtenbeek TB, Krooshoop DJ, Bleijs DA et al. DC-SIGN-ICAM-2 interaction mediates dendritic cell trafficking. Nat Immunol 2000; 1:353-357.
45. Geijtenbeek TB, Torensma R, van Vliet SJ et al. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 2000; 100:575-585.
46. Curtis BM, Scharnowske S, Watson AJ. Sequence and expression of a membrane-associated C-type lectin that exhibits CD4-independent binding of human immunodeficiency virus envelope glycoprotein gp120. Proc Natl Acad Sci USA 1992; 89:8356-8360.
47. Geijtenbeek TB, Kwon DS, Torensma R et al. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 2000; 100:587-597.
48. Pohlmann S, Zhang J, Baribaud F et al. Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR. J Virol 2003; 77:4070-4080.
49. Tassaneetrithep B, Burgess TH, Granelli-Piperno A et al. DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. J Exp Med 2003; 197:823-829.
50. Colmenares M, Puig-Kroger A, Pello OM et al. Dendritic cell (DC)-specific intercellular adhesion molecule 3 (ICAM-3)-grabbing nonintegrin (DC-SIGN, CD209), a C-type surface lectin in human DCs, is a receptor for Leishmania amastigotes. J Biol Chem 2002; 277:36766-36769.
51. Geijtenbeek TB, Van Vliet SJ, Koppel EA et al. Mycobacteria target DC-SIGN to suppress dendritic cell function. J Exp Med 2003; 197:7-17.
52. Tailleux L, Schwartz O, Herrmann JL et al. DC-SIGN is the major Mycobacterium tuberculosis receptor on human dendritic cells. J Exp Med 2003; 197:121-127.
53. Simmons G, Reeves JD, Grogan CC et al. DC-SIGN and DC-SIGNR bind ebola glycoproteins and enhance infection of macrophages and endothelial cells. Virology 2003; 305:115-123.
54. Kaushal GP, Elbein AD. Glycosidase inhibitors in study of glycoconjugates. Methods Enzymol 1994; 230:316-329.
55. Lin G, Simmons G, Pohlmann S et al. Differential N-linked glycosylation of human immunodeficiency virus and Ebola virus envelope glycoproteins modulates interactions with DC-SIGN and DC-SIGNR. J Virol 2003; 77:1337-1346.
56. Mitchell DA, Fadden AJ, Drickamer K. A novel mechanism of carbohydrate recognition by the C-type lectins DC-SIGN and DC-SIGNR. Subunit organization and binding to multivalent ligands. J Biol Chem 2001; 276:28939-28945.
57. Davis CW, Nguyen HY, Hanna SL et al. West Nile virus discriminates between DC-SIGN and DC-SIGNR for cellular attachment and infection. J Virol 2006; 80:1290-1301.
58. Feldmann H, Nichol ST, Klenk HD et al. Characterization of filoviruses based on differences in structure and antigenicity of the virion glycoprotein. Virology 1994; 199:469-473.
59. Powlesland AS, Fisch T, Taylor ME et al. A novel mechanism for LSECtin binding to Ebola virus surface glycoprotein through truncated glycans. J Biol Chem 2008; 283(1):593-602.
60. Alvarez CP, Lasala F, Carrillo J et al. C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans. J Virol 2002; 76:6841-6844.
61. Marzi A, Gramberg T, Simmons G et al. DC-SIGN and DC-SIGNR interact with the glycoprotein of Marburg virus and the S protein of severe acute respiratory syndrome coronavirus. J Virol 2004; 78:12090-12095.
62. Gramberg T, Hofmann H, Moller P et al. LSECtin interacts with filovirus glycoproteins and the spike protein of SARS coronavirus. Virology 2005; 340:224-36.
63. Soilleux EJ, Morris LS, Leslie G et al. Constitutive and induced expression of DC-SIGN on dendritic cell and macrophage subpopulations in situ and in vitro. J Leukoc Biol 2002; 71:445-457.
64. Soilleux EJ, Morris LS, Lee B et al. Placental expression of DC-SIGN may mediate intrauterine vertical transmission of HIV. J Pathol 2001; 195:586-592.
65. McCully ML, Chau TA, Luke P et al. Characterization of human peritoneal dendritic cell precursors and their involvement in peritonitis. Clin Exp Immunol 2005; 139:513-525.
66. Lai WK, Sun PJ, Zhang J et al. Expression of DC-SIGN and DC-SIGNR on human sinusoidal endothelium: a role for capturing hepatitis C virus particles. Am J Pathol 2006; 169:200-208.
67. Bashirova AA, Geijtenbeek TB, van Duijnhoven GC et al. A dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin (DC-SIGN)-related protein is highly expressed on human liver sinusoidal endothelial cells and promotes HIV-1 infection. J Exp Med 2001; 193:671-678.
68. Becker S, Spiess M, Klenk HD. The asialoglycoprotein receptor is a potential liver-specific receptor for Marburg virus. J Gen Virol 1995; 76:393-399.
69. Meier M, Bider MD, Malashkevich VN et al. Crystal structure of the carbohydrate recognition domain of the H1 subunit of the asialoglycoprotein receptor. J Mol Biol 2000; 300:857-865.
70. Takada A, Fujioka K, Tsuiji M et al. Human macrophage C-type lectin specific for galactose and N-acetylgalactosamine promotes filovirus entry. J Virol 2004; 78:2943-2947.
71. Sieczkarski SB, Whittaker GR. Dissecting virus entry via endocytosis. J Gen Virol 2002; 83:1535-1545.
72. Empig CJ, Goldsmith MA. Association of the caveola vesicular system with cellular entry by filoviruses. J Virol 2002; 76:5266-5270.
73. Bavari S, Bosio CM, Wiegand E et al. Lipid raft microdomains: a gateway for compartmentalized trafficking of Ebola and Marburg viruses. J Exp Med 2002; 195:593-602.
74. Bhattacharyya S, Warfield KL, Ruthel G et al. Ebola virus uses clathrin-mediated endocytosis as an entry pathway. Virology 2010; 401:18-28.
75. Saeed MF, Kolokoltsov AA, Albrecht T et al. Cellular entry of ebola virus involves uptake by a macropinocytosis-like mechanism and subsequent trafficking through early and late endosomes. PLoS Pathog 2010; 6:e1001110.
76. Nanbo A, Imai, M, Watanabe S et al. Ebolavirus is internalized into host cells via macropinocytosis in a viral glycoprotein-dependent manner. PLoS Pathog 2010; 6:e1001121.
77. Aleksandrowicz P, Marzi A, Biedenkopf N et al. Ebola virus enters host cells by macropinocytosis and clathrin-mediated endocytosis. J Infect Dis 2011; 204:S957-S967.
78. Hunt CL, Kolokoltsov AA, Davey RA et al. The tyro3 receptor kinase axl enhances macropinocytosis of zaire ebolavirus. J Virol 2011; 85:334-347.
79. Eckert DM, Kim PS. Mechanisms of viral membrane fusion and its inhibition. Annu Rev Biochem. 2001;70:777-810.
80. Mothes W, Boerger AL, Narayan S et al. Retroviral entry mediated by receptor priming and low pH triggering of an envelope glycoprotein. Cell 2000; 103(4):679-689.
81. Bar S, Takada A, Kawaoka Y et al. Detection of cell-cell fusion mediated by Ebola virus glycoproteins. J Virol 2006; 80(6):2815-2822.
82. Ito H, Watanabe S, Sanchez A et al. Mutational analysis of the putative fusion domain of Ebola virus glycoprotein. J Virol 1999; 73(10):8907-8912.
83. Simmons G, Reeves JD, Rennekamp AJ et al. Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry. Proc Natl Acad Sci USA 2004; 101(12):4240-4245.
84. Chandran K, Sullivan NJ, Felbor U et al. Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection. Science 2005; 308(5728):1643-1645.
85. Schornberg K, Matsuyama S, Kabsch K et al. Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein. J Virol 2006; 80(8):4174-4178.
86. Misasi J, Chandran K, Yang JY et al. Filoviruses require endosomal cysteine proteases for entry but exhibit distinct protease preferences. J Virol 2012; 86(6):3284-3292.
87. Gnirss K, Kuhl A, Karsten C et al. Cathepsins B and L activate Ebola but not Marburg virus glycoproteins for efficient entry into cell lines and macrophages independent of TMPRSS2 expression. Virology 2012; 424(1):3-10.
88. Ebert DH, Deussing J, Peters C et al. Cathepsin L and cathepsin B mediate reovirus disassembly in murine fibroblast cells. J Biol Chem 2002; 277(27):24609-24617.
89. Simmons G, Gosalia DN, Rennekamp AJ et al. Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry. Proc Natl Acad Sci USA 2005; 102(33):11876-11881.
90. Qiu Z, Hingley ST, Simmons G et al. Endosomal proteolysis by cathepsins is necessary for murine coronavirus mouse hepatitis virus type 2 spike-mediated entry. J Virol 2006; 80(12):5768-5776.
91. Carette JE, Raaben M, Wong AC et al. Ebola virus entry requires the cholesterol transporter Niemann-Pick C1. Nature 2011; 477(7364):340-343.
92. Cote M, Misasi J, Ren T et al. Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection. Nature 2011; 477(7364):344-348.
93. Miller EH, Obernosterer G, Raaben M et al. Ebola virus entry requires the host-programmed recognition of an intracellular receptor. EMBO J 2012; 31(8):1947-1960.